<DOC>
	<DOCNO>NCT01362010</DOCNO>
	<brief_summary>The purpose study evaluate tolerability safety determine whether FXFM244 Antibiotic Foam effective treatment Acne Vulgaris .</brief_summary>
	<brief_title>Clinical Study Evaluate Tolerability Safety FXFM244 Monitor Clinical Effect Acne Vulgaris Patients</brief_title>
	<detailed_description>This phase IIa prospective , multicenter , randomize , double blind , placebo control , parallel group , dose range find clinical study evaluate safety , tolerability efficacy Minocycline Foam 1 % 4 % treatment Acne Vulgaris . The study consist screen / baseline visit , treatment period patient treat topically facial skin area affect acne twice daily 12 week , follow post-treatment follow visit 4 week end treatment . The first dose apply presence study investigator assignee . Subsequent application make patient .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>A clinical diagnosis Acne Vulgaris facial involvement . A minimum 20 50 inflammatory lesion face ( papule and/ pustule ) . A minimum 25 100 noninflammatory lesion face ( open and/or closed comedo ) . No significant nodulocystic acne face ( ≤ 2 lesion ) . A score &gt; 3 ( Moderate ) Investigator 's Global Assessment Scale . Patient male female age 12 25 . No known medical condition , Investigator 's opinion could interfere study participation . Patient willing refrain use topical acne medication antibiotic study . Patient willing refrain use moisturizers , new brand makeup , cream , lotion , powder topical product assign treatment treatment area . Patient willing able comply requirement protocol . Patient willing able give write informed consent prior participation study . If female childbearing potential , willing use acceptable form birth control study . Use oral contraceptive must remain constant within 3 month prior baseline throughout study . Acne Conglobata , Acne Fulminas , secondary acne ( chloracne , drug induce acne ) , severe acne require systemic treatment . Presence facial skin condition would interfere diagnosis assessment Acne Vulgaris ( e.g . rosacea , dermatitis , psoriasis , squamos cell carcinoma , eczema , acneform eruption cause medication , steroid acne , steroid folliculitis , bacterial folliculitis ) . Excessive facial hair ( beard , sideburn , moustache , etc . ) would interfere diagnosis assessment Acne Vulgaris . Known suspect hypersensitivity Minocycline excipients Study Medication . Concomitant medication : Use within 6 month prior baseline topical retinoids , oral retinoids ( Accutane® ) therapeutic Protocol No . FX201003 Foamix Ltd . Page 8 28 Confidential Ver : 02 Oct312011 vitamin A supplement great 10,000 units/day ( multivitamin allow ) . Use systemic steroid , systemic antibiotic , systemic treatment Acne Vulgaris , systemic antiinflammatory agent within 4 week prior baseline . Use topical steroid , αhydroxy/glycolic acid , benzoyl peroxide , topical antibiotic , topical treatment Acne Vulgaris , topical antiinflammatory agent within 2 week prior baseline . Use le 3 month prior baseline estrogen change oral contraceptive therapy within less 3 month prior baseline ; Use face : cryodestruction chemodestruction , dermabrasion , photodynamic therapy , acne surgery , intralesional steroid Xray therapy within 4 week prior baseline.. Alcohol drug abuse , accord assessment investigator . Use another investigational drug within 30 day prior baseline . Pregnant lactating woman . Use tanning booth , sunbathe , excessive exposure sun prohibit study . Participation clinical trial previous month .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Acne</keyword>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Topical</keyword>
	<keyword>Minocycline</keyword>
	<keyword>Foam</keyword>
	<keyword>Phase II</keyword>
</DOC>